0001213900-20-028522.txt : 20200928 0001213900-20-028522.hdr.sgml : 20200928 20200925194040 ACCESSION NUMBER: 0001213900-20-028522 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200831 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200928 DATE AS OF CHANGE: 20200925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bespoke Extracts, Inc. CENTRAL INDEX KEY: 0001409197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204743354 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-52759 FILM NUMBER: 201201772 BUSINESS ADDRESS: STREET 1: 323 SUNNY ISLES BOULEVARD STREET 2: SUITE 700 CITY: SUNNY ISLES STATE: FL ZIP: 33160 BUSINESS PHONE: 855-633-3738 MAIL ADDRESS: STREET 1: 323 SUNNY ISLES BOULEVARD STREET 2: SUITE 700 CITY: SUNNY ISLES STATE: FL ZIP: 33160 FORMER COMPANY: FORMER CONFORMED NAME: DiMi Telematics International, Inc. DATE OF NAME CHANGE: 20120319 FORMER COMPANY: FORMER CONFORMED NAME: FIRST QUANTUM VENTURES INC DATE OF NAME CHANGE: 20071106 FORMER COMPANY: FORMER CONFORMED NAME: First Quantum Ventures Inc DATE OF NAME CHANGE: 20070808 8-K 1 ea127422-8k_bespokeextracts.htm CURRENT REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 31, 2020

 

Bespoke Extracts, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   000-52759   20-4743354
(State or other jurisdiction
of incorporation)		   (Commission
File Number)		   (IRS Employer
Identification No.)

 

323 Sunny Isles Boulevard, Suite 700

Sunny Isles Beach, FL 33160

(Address of principal executive offices) (Zip Code)

 

Registrant's telephone number, including area code (855) 633-3738

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

  

 

 

1

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On August 31, 2020, Bespoke Extracts, Inc. (the “Company”) issued a promissory note in the principal amount of $150,000, to Danil Pollack, the Company’s chief executive officer. Upon execution of the note, $120,000 was remitted and the remaining $30,000 was paid on September 22, 2020. The note does not bear interest and matures on November 30, 2020.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information under Item 1.01 is incorporated by reference into this Item 2.03.

  

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No. Description
   
10.1 Promissory Note

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Bespoke Extracts, Inc.  
     
Date: September 25, 2020 By: /s/ Danil Pollack
   

Danil Pollack

Chief Executive Officer

 

 

3

 

 

 EX-10.1 2 ea127422ex10-1_bespoke.htm PROMISSORY NOTE

Exhibit 10.1

 

$150,000 August 31, 2020

 

PROMISSORY NOTE

 

FOR VALUE RECEIVED, Bespoke Extracts, Inc., a Nevada corporation (the “Company”) hereby promises to pay to Danil Pollack (“Holder”), in lawful money of the United States of America, the principal sum of One Hundred Fifty Thousand Dollars ($150,000), on November 30, 2020 (the “Maturity Date”).

 

This Note will not bear interest.

 

The Company shall have the right to prepay, at any time and from time to time without premium or penalty, the entire unpaid principal balance of this Note or any portion thereof.

 

This Note shall be governed by and construed in accordance with the internal laws of the State of New York. Holder and Company hereby irrevocably submit to the exclusive jurisdiction of any federal or state court located within the County of New York over any dispute relating to this Note and Company and Holder each hereby irrevocably agree that all claims in respect of such dispute or any suit, action or proceeding related thereto may be heard and determined in such courts.

 

IN WITNESS WHEREOF, the undersigned has caused this Note to be executed as of the day and year first above written.

 

  Bespoke Extracts, Inc.
     
  By: /s/ Danil Pollack
  Name: Danil Pollack
  Title: Chief Executive Officer